Metástase cerebral no câncer de pulmão: sintomas, terapias-alvo e tratamento

Receiving a diagnosis of brain metastasis in lung cancer often generates many doubts and concerns. However, recent advances in oncology have significantly changed how this condition is treated, offering new possibilities for disease control and improved quality of life for many patients. In this content, we explain clearly and accessibly what brain metastasis is, what symptoms deserve attention, how the diagnosis works, and why targeted therapies have revolutionized the treatment of patients with specific mutations, such as EGFR and ALK. 🔍 What you will find in this guide: What is brain metastasis in lung cancer? Understand how lung tumor cells can reach the brain and why the disease continues to be treated as lung cancer, even when there is brain involvement. Why lung cancer frequently spreads to the brain Learn about the biological factors involved and the relationship between certain genetic alterations and the increased risk of brain metastases. Main Symptoms Requiring Attention Learn to identify signs such as persistent headaches, seizures, neurological changes, speech difficulties, behavioral changes, and balance problems. How the Diagnosis is Made See the role of magnetic resonance imaging, molecular tests, and specialized evaluation in defining the best treatment. Targeted Therapies for EGFR Mutations Understand how drugs like osimertinib can cross the blood-brain barrier and control brain lesions with high response rates. Treatment for Tumors with ALK Rearrangement Learn about the role of alectinib and lorlatinib, drugs that exhibit excellent intracranial activity and can reduce the need for immediate local treatments. Other Treatable Mutations Learn how alterations such as ROS1, MET, RET, and KRAS can influence therapeutic choices and broaden treatment options. What to Do When No Mutation Identified Understand when radiotherapy, immunotherapy, chemotherapy, and radiosurgery may be recommended. Current Prognosis and Perspectives Learn about the factors that influence the progression of the disease and how advances in modern therapies are changing clinical outcomes. Brain metastasis in lung cancer requires individualized assessment and monitoring by a multidisciplinary team. Therapeutic decisions should always consider the characteristics of the tumor, the molecular profile of the disease, and the goals of each patient. Evidence-based information is fundamental for safe and informed decision-making. 👍 Did this content help clarify treatment options? Like and share with patients and family members who also need reliable and up-to-date information. 🔔 Subscribe to the channel to follow more content about lung cancer, brain metastasis, targeted therapies, immunotherapy, and oncology. Dr. Hugo Tanaka Clinical Oncologist CRM 163241 | RQE 100689 – Clinical Oncology Website: https://drhugotanaka.com.br/